These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39119242)
21. Nutlin-3a suppresses poly (ADP-ribose) polymerase 1 by mechanisms different from conventional PARP1 suppressors in a human breast cancer cell line. Kobayashi M; Ishizaki Y; Owaki M; Matsumoto Y; Kakiyama Y; Hoshino S; Tagawa R; Sudo Y; Okita N; Akimoto K; Higami Y Oncotarget; 2020 May; 11(18):1653-1665. PubMed ID: 32405340 [TBL] [Abstract][Full Text] [Related]
22. [Influence of the Poly(ADP-Ribose) Polymerase 1 Level on the Status of Base Excision Repair in Human Cells]. Ilina ES; Kochetkova AS; Belousova EA; Kutuzov MM; Lavrik OI; Khodyreva SN Mol Biol (Mosk); 2023; 57(2):285-298. PubMed ID: 37000656 [TBL] [Abstract][Full Text] [Related]
23. Role of YB-1 in Regulation of Poly(ADP-Ribosylation) Catalyzed by Poly(ADP-Ribose) Polymerases. Alemasova EE; Naumenko KN; Sukhanova MV; Lavrik OI Biochemistry (Mosc); 2022 Jan; 87(Suppl 1):S32-S0. PubMed ID: 35501985 [TBL] [Abstract][Full Text] [Related]
24. Phosphatase 1 Nuclear Targeting Subunit Mediates Recruitment and Function of Poly (ADP-Ribose) Polymerase 1 in DNA Repair. Wang F; Zhu S; Fisher LA; Wang L; Eurek NJ; Wahl JK; Lan L; Peng A Cancer Res; 2019 May; 79(10):2526-2535. PubMed ID: 30733193 [TBL] [Abstract][Full Text] [Related]
25. The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers. Kamaletdinova T; Fanaei-Kahrani Z; Wang ZQ Cells; 2019 Dec; 8(12):. PubMed ID: 31842403 [TBL] [Abstract][Full Text] [Related]
26. Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection. Rageul J; Lo N; Phi AL; Patel JA; Park JJ; Kim H Cell Rep; 2024 Mar; 43(3):113845. PubMed ID: 38393943 [TBL] [Abstract][Full Text] [Related]
27. Poly(ADP-ribose) Polymerase 1 Modulates Interaction of the Nucleotide Excision Repair Factor XPC-RAD23B with DNA via Poly(ADP-ribosyl)ation. Maltseva EA; Rechkunova NI; Sukhanova MV; Lavrik OI J Biol Chem; 2015 Sep; 290(36):21811-20. PubMed ID: 26170451 [TBL] [Abstract][Full Text] [Related]
28. Insight into DNA substrate specificity of PARP1-catalysed DNA poly(ADP-ribosyl)ation. Matta E; Kiribayeva A; Khassenov B; Matkarimov BT; Ishchenko AA Sci Rep; 2020 Feb; 10(1):3699. PubMed ID: 32111879 [TBL] [Abstract][Full Text] [Related]
29. Regulatory apoptotic fragment of PARP1 complements catalytic fragment for PAR and DNA-dependent activity but inhibits DNA-induced catalytic stimulation of PARP2. Deeksha W; Rajakumara E DNA Repair (Amst); 2024 Jan; 133():103593. PubMed ID: 38029688 [TBL] [Abstract][Full Text] [Related]
31. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging. Zhang H; Lin X; Zha S Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996 [TBL] [Abstract][Full Text] [Related]
32. DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation. Chen Y; Yao Y; Zhao K; Liu C; Yuan Y; Sun H; Huang D; Zheng Y; Zhou Y; Chen J; Wang Y; Wu C; Zhang B; Guan Y; Li F; Pei R; Chen X J Virol; 2022 Jul; 96(13):e0058522. PubMed ID: 35862693 [TBL] [Abstract][Full Text] [Related]
33. Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity. Chen HD; Chen CH; Wang YT; Guo N; Tian YN; Huan XJ; Song SS; He JX; Miao ZH Int J Cancer; 2019 Aug; 145(3):714-727. PubMed ID: 30675909 [TBL] [Abstract][Full Text] [Related]
34. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress. Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463 [TBL] [Abstract][Full Text] [Related]
35. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA. Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992 [TBL] [Abstract][Full Text] [Related]
36. Mammalian N1-adenosine PARylation is a reversible DNA modification. Musheev MU; Schomacher L; Basu A; Han D; Krebs L; Scholz C; Niehrs C Nat Commun; 2022 Oct; 13(1):6138. PubMed ID: 36253381 [TBL] [Abstract][Full Text] [Related]
37. BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8. Yan Q; Xu R; Zhu L; Cheng X; Wang Z; Manis J; Shipp MA Mol Cell Biol; 2013 Feb; 33(4):845-57. PubMed ID: 23230272 [TBL] [Abstract][Full Text] [Related]
38. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase. Rudolph J; Roberts G; Muthurajan UM; Luger K Elife; 2021 Mar; 10():. PubMed ID: 33683197 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus Viral Processivity Factor EA-D Facilitates Virus Lytic Replication by Inducing Poly(ADP-Ribose) Polymerase 1 Degradation. Lee S; Kim J; Chung WC; Han JH; Song MJ J Virol; 2022 Nov; 96(21):e0037122. PubMed ID: 36286483 [TBL] [Abstract][Full Text] [Related]
40. The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1. Fischbach A; Krüger A; Hampp S; Assmann G; Rank L; Hufnagel M; Stöckl MT; Fischer JMF; Veith S; Rossatti P; Ganz M; Ferrando-May E; Hartwig A; Hauser K; Wiesmüller L; Bürkle A; Mangerich A Nucleic Acids Res; 2018 Jan; 46(2):804-822. PubMed ID: 29216372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]